Gainers
- Revance Therapeutics RVNC shares increased by 15.3% to $24.0 during Thursday's pre-market session. The company's market cap stands at $1.7 billion.
- Ayala Pharmaceuticals AYLA stock rose 14.28% to $2.0. The market value of their outstanding shares is at $29.5 million.
- Idera Pharmaceuticals IDRA shares moved upwards by 13.59% to $0.57. The company's market cap stands at $30.1 million.
- AcelRx Pharmaceuticals ACRX stock increased by 13.21% to $0.33. The company's market cap stands at $48.2 million.
- PhaseBio Pharmaceuticals PHAS shares increased by 13.2% to $1.2. The company's market cap stands at $59.8 million.
- ORIC Pharmaceuticals ORIC shares moved upwards by 13.04% to $3.9. The market value of their outstanding shares is at $154.3 million.
Losers
- Chembio Diagnostics CEMI stock fell 15.4% to $0.53 during Thursday's pre-market session. The company's market cap stands at $16.0 million.
- Biophytis BPTS stock declined by 11.72% to $0.98. The market value of their outstanding shares is at $16.0 million.
- Nanobiotix NBTX stock fell 10.49% to $3.84. The company's market cap stands at $133.9 million.
- BioVie BIVI stock declined by 8.04% to $2.86. The company's market cap stands at $81.8 million.
- Apexigen APGN shares declined by 7.15% to $7.02. The market value of their outstanding shares is at $150.5 million.
- Spero Therapeutics SPRO stock declined by 7.0% to $1.33. The market value of their outstanding shares is at $46.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in